Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis. | Aging (Albany NY) | 2021 | 33744866 | PubTator, text mining | PubMed |
| Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1. | NPJ Precis Oncol | 2021 | 33742100 | PubTator, text mining | PubMed |
| Stabilisation of half MCM ring by Cdt1 during DNA insertion. | Nat Commun | 2021 | 33741931 | PubTator, text mining | PubMed |
| ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | Hum Mol Genet | 2021 | 33729478 | PubTator, text mining | PubMed |
| Expression and prognosis analysis of GINS subunits in human breast cancer. | Medicine (Baltimore) | 2021 | 33725952 | PubTator, text mining | PubMed |
| Functional differences and similarities in activated peripheral blood mononuclear cells by lipopolysaccharide or phytohemagglutinin stimulation between human and cynomolgus monkeys. | Ann Transl Med | 2021 | 33708884 | PubTator, text mining | PubMed |
| The In Vivo Selection Method in Breast Cancer Metastasis. | Int J Mol Sci | 2021 | 33672831 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Caco-2 Cells upon the Exposure of Mycotoxin Deoxynivalenol and Its Acetylated Derivatives. | Toxins (Basel) | 2021 | 33671637 | PubTator, text mining | PubMed |
| Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway. | Aging (Albany NY) | 2021 | 33668040 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2. | Mol Cancer | 2021 | 33658012 | PubTator, text mining | PubMed |
| MCM complex members MCM3 and MCM7 are associated with a phenotypic spectrum from Meier-Gorlin syndrome to lipodystrophy and adrenal insufficiency. | Eur J Hum Genet | 2021 | 33654309 | PubTator, text mining | PubMed |
| Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review). | Oncol Rep | 2021 | 33649804 | PubTator, text mining | PubMed |
| DDK regulates replication initiation by controlling the multiplicity of Cdc45-GINS binding to Mcm2-7. | Elife | 2021 | 33616038 | PubTator, text mining | PubMed |
| The DNA replication regulator MCM6: An emerging cancer biomarker and target. | Clin Chim Acta | 2021 | 33609557 | PubTator, text mining | PubMed |
| Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells. | Sci Rep | 2021 | 33608585 | PubTator, text mining | PubMed |
| Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments. | Life Sci | 2021 | 33607151 | PubTator, text mining | PubMed |
| A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2021 | 33604252 | PubTator, text mining | PubMed |
| Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. | Technol Cancer Res Treat | 2021 | 33596783 | PubTator, text mining | PubMed |
| Persistence of RNA transcription during DNA replication delays duplication of transcription start sites until G2/M. | Cell Rep | 2021 | 33596418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=34